Morgan Stanley raised the firm’s price target on Synchrony (SYF) to $72 from $70 and keeps an Equal Weight rating on the shares. The company reported a “low quality” earnings beat in Q2 as its loan growth remains “sluggish,” the analyst tells investors in a research note. The firm, however, it optimistic on Synchrony’s tone regarding loan growth in 2026.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYF:
- Synchrony announces strategic partnership with Dental Intelligence
- Synchrony price target raised to $78 from $75 at RBC Capital
- Strong Credit Discipline and Strategic Focus Support Buy Rating for Synchrony Financial
- Mixed Signals in Synchrony Financial’s Outlook: Hold Rating Amid Growth Opportunities and Risks
- Synchrony price target lowered to $80 from $81 at Barclays